You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-18. Frequency of use of primary drug of clients entering treatment, 2010 or most recent year available
Part (iv) All inpatient clients by primary drug and frequency of use (%)
| Primary drug | Not used in the past month/occasional | Once a week or less | 2–6 times per week | Daily | Frequency known (n) | Frequency unknown | |
|---|---|---|---|---|---|---|---|
| Opioids | 14.5 | 5.9 | 14.6 | 65.0 | 9674 | 872 | |
| Cocaine | 24.0 | 7.8 | 23.8 | 44.5 | 1010 | 232 | |
| Stimulants | 23.6 | 10.9 | 30.2 | 35.3 | 3234 | 251 | |
| Cannabis | 13.1 | 9.4 | 20.4 | 57.1 | 2924 | 421 |
Notes:
Percentages are of clients whose frequency of use is known (n)
Only countries reporting data related to primary drug have been included.
The following countries have been included:BE, BG, CZ, DK, IE, GR, FR, CY, LU, HU, NL, AT, RO, SK, FI, SE, HR, TR
See also Table TDI-112 for distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page.
Source:
Reitox national reports 2011 — TDI table — inpatient treatment centres.